Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 185

1.

Chriolepis prolata, a new species of Atlantic goby (Teleostei: Gobiidae) from the North American continental shelf.

Hastings PA, Findley LT.

Zootaxa. 2015 Jan 8;3904(1):589-95. doi: 10.11646/zootaxa.3904.4.8.

PMID:
25660803
2.

Long-term effectiveness of dopamine agonists and monoamine oxidase B inhibitors compared with levodopa as initial treatment for Parkinson's disease (PD MED): a large, open-label, pragmatic randomised trial.

PD Med Collaborative Group, Gray R, Ives N, Rick C, Patel S, Gray A, Jenkinson C, McIntosh E, Wheatley K, Williams A, Clarke CE.

Lancet. 2014 Sep 27;384(9949):1196-205. doi: 10.1016/S0140-6736(14)60683-8. Epub 2014 Jun 11. Erratum in: Lancet. 2014 Sep 27;384(9949):1186.

PMID:
24928805
3.

Convergent evolution of ecomorphological adaptations in geographically isolated Bay gobies (Teleostei: Gobionellidae) of the temperate North Pacific.

Ellingson RA, Swift CC, Findley LT, Jacobs DK.

Mol Phylogenet Evol. 2014 Jan;70:464-77. doi: 10.1016/j.ympev.2013.10.009. Epub 2013 Oct 19.

PMID:
24148989
4.

Chriolepis bilix, a new species of goby (Teleostei: Gobiidae) from deep waters of the western Atlantic.

Hastings PA, Findley LT.

Zootaxa. 2013 Dec 9;3745:596-600. doi: 10.11646/zootaxa.3745.5.8.

PMID:
25113374
5.

A cost-effectiveness analysis of levodopa/carbidopa intestinal gel compared to standard care in late stage Parkinson's disease in the UK.

Lowin J, Bergman A, Chaudhuri KR, Findley LJ, Roeder C, Schifflers M, Wood E, Morris S.

J Med Econ. 2011;14(5):584-93. doi: 10.3111/13696998.2011.598201. Epub 2011 Jul 6.

PMID:
21728911
6.

The economic burden of advanced Parkinson’s disease: an analysis of a UK patient dataset.

Findley LJ, Wood E, Lowin J, Roeder C, Bergman A, Schifflers M.

J Med Econ. 2011;14(1):130-9. doi: 10.3111/13696998.2010.551164.

PMID:
21235405
7.

A basic smell test is as sensitive as a dopamine transporter scan: comparison of olfaction, taste and DaTSCAN in the diagnosis of Parkinson's disease.

Deeb J, Shah M, Muhammed N, Gunasekera R, Gannon K, Findley LJ, Hawkes CH.

QJM. 2010 Dec;103(12):941-52. doi: 10.1093/qjmed/hcq142. Epub 2010 Aug 23.

8.

Abnormality of taste and smell in Parkinson's disease.

Shah M, Deeb J, Fernando M, Noyce A, Visentin E, Findley LJ, Hawkes CH.

Parkinsonism Relat Disord. 2009 Mar;15(3):232-7. doi: 10.1016/j.parkreldis.2008.05.008. Epub 2008 Jul 7.

PMID:
18606556
9.

Fourteen-year final report of the randomized PDRG-UK trial comparing three initial treatments in PD.

Katzenschlager R, Head J, Schrag A, Ben-Shlomo Y, Evans A, Lees AJ; Parkinson's Disease Research Group of the United Kingdom.

Neurology. 2008 Aug 12;71(7):474-80. doi: 10.1212/01.wnl.0000310812.43352.66. Epub 2008 Jun 25.

PMID:
18579806
10.

Olfactory tests in the diagnosis of essential tremor.

Shah M, Muhammed N, Findley LJ, Hawkes CH.

Parkinsonism Relat Disord. 2008 Nov;14(7):563-8. doi: 10.1016/j.parkreldis.2007.12.006. Epub 2008 Mar 5.

PMID:
18321760
11.

The economic impact of Parkinson's disease.

Findley LJ.

Parkinsonism Relat Disord. 2007 Sep;13 Suppl:S8-S12. Epub 2007 Aug 16. Review.

PMID:
17702630
12.

A multicentre longitudinal observational study of changes in self reported health status in people with Parkinson's disease left untreated at diagnosis.

Grosset D, Taurah L, Burn DJ, MacMahon D, Forbes A, Turner K, Bowron A, Walker R, Findley L, Foster O, Patel K, Clough C, Castleton B, Smith S, Carey G, Murphy T, Hill J, Brechany U, McGee P, Reading S, Brand G, Kelly L, Breen K, Ford S, Baker M, Williams A, Hearne J, Qizilbash N, Chaudhuri KR.

J Neurol Neurosurg Psychiatry. 2007 May;78(5):465-9. Epub 2006 Nov 10.

13.

Cost-effectiveness of levodopa/carbidopa/entacapone (Stalevo) compared to standard care in UK Parkinson's disease patients with wearing-off.

Findley LJ, Lees A, Apajasalo M, Pitkänen A, Turunen H.

Curr Med Res Opin. 2005 Jul;21(7):1005-14.

PMID:
16004667
14.

Retrospective evaluation of the dose of Dysport and BOTOX in the management of cervical dystonia and blepharospasm: the REAL DOSE study.

Marchetti A, Magar R, Findley L, Larsen JP, Pirtosek Z, Růzicka E, Jech R, Sławek J, Ahmed F.

Mov Disord. 2005 Aug;20(8):937-44. Erratum in: Mov Disord. 2005 Aug;20(8):1089. Råuzizka, Evzen [corrected to Růzicka, Evzen].

PMID:
15810022
15.

The Parkinson fatigue scale.

Brown RG, Dittner A, Findley L, Wessely SC.

Parkinsonism Relat Disord. 2005 Jan;11(1):49-55.

PMID:
15619463
16.
17.

Nature vs. nurture: two brothers with schizophrenia.

Keltner NL, James CA, Darling RJ, Findley LS, Oliver K.

Perspect Psychiatr Care. 2001 Jul-Sep;37(3):88-94. Review.

PMID:
15521296
18.

Expanding clinical dimensions of essential tremor.

Findley LJ.

J Neurol Neurosurg Psychiatry. 2004 Jul;75(7):948-9. No abstract available.

19.

Reducing motor-vehicle collisions, costs, and fatalities by treating obstructive sleep apnea syndrome.

Sassani A, Findley LJ, Kryger M, Goldlust E, George C, Davidson TM.

Sleep. 2004 May 1;27(3):453-8.

PMID:
15164898
20.

Randomized, double-blind, 3-month parallel study of the effects of pramipexole, pergolide, and placebo on Parkinsonian tremor.

Navan P, Findley LJ, Jeffs JA, Pearce RK, Bain PG.

Mov Disord. 2003 Nov;18(11):1324-31.

PMID:
14639675
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk